By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Commission (EC) 

Rue Joseph II
Jozef II straat 70
Brussels    B-1000  Belgium
Phone: n/a Fax: n/a


Medical Device

Company News
ProMetic Life Sci (PFSCF.PK) Releaase: European Commission (EC) Grants Orphan Drug Designation To Company's PBI-4050 Drug For The Treatment Of Alström Syndrome 1/18/2017 7:54:11 AM
Oncurious Release: Company Announces European Commission (EC) Confirmed Orphan Medicinal Product Designation For TB-403 For Medulloblastoma 1/17/2017 11:00:30 AM
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Vemlidy (Tenofovir Alafenamide, TAF) For The Treatment Of Chronic Hepatitis B Virus Infection 1/11/2017 10:01:12 AM
PTC Therapeutics (PTCT) Release: European Commission (EC) Ratifies Positive CHMP Opinion For The Renewal Of Translarna Marketing Authorization For The Treatment Of Nonsense Mutation Duchenne Muscular Dystrophy 1/10/2017 11:07:31 AM
Advanced Accelerator Applications Announces European Commission (EC) Approval Of SomaKit TOC 12/15/2016 7:50:03 AM
European Commission (EC) Grants Intercept Pharma (ICPT)’s Ocaliva (Obeticholic Acid) Marketing Authorization For The Treatment Of Primary Biliary Cholangiti 12/14/2016 7:13:56 AM
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: NINLARO (Ixazomib) Receives Conditional Approval From The European Commission (EC) To Treat Multiple Myeloma 11/28/2016 12:46:11 PM
European Commission (EC) Approves Bristol-Myers Squibb (BMY)'s Opdivo(Nivolumab) For The Treatment Of Adult Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant And Treatment With Brentuximab Vedotin 11/23/2016 10:51:16 AM
Janssen Pharmaceutical Companies Release: Phase 3 Study Results Supporting U.S. FDA And European Commission (EC) Approvals Of STELARA In The Treatment Of Moderately To Severely Active Crohn's Disease Published In The New England Journal of Medicine 11/17/2016 7:17:31 AM
Amgen (AMGN) Release: European Commission (EC) Approves Parsabiv (etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adults On Hemodialysis 11/14/2016 7:37:19 AM